STOCK TITAN

Cushman & Wakefield Ltd 10-Q Filings

CWK NYSE

Every 10-Q that Cushman & Wakefield Ltd (CWK) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow CWK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CWK filings page.

Rhea-AI Summary

Cushman & Wakefield Ltd. reported first‑quarter 2026 results showing higher revenue but a small loss. Revenue reached $2,535.8 million, up from $2,284.6 million a year earlier, with growth across Services, Leasing, Capital markets, and Valuation.

The company posted a net loss of $12.6 million versus net income of $1.9 million in 2025, or loss per share of $0.05 compared with earnings of $0.01. Results were weighed down by a $16.6 million non‑cash pension buy‑out settlement loss and an $11.8 million non‑cash servicing liability related to amending its accounts receivable securitization program.

Adjusted EBITDA, which excludes these and other items, was $111.3 million, up from $96.2 million, reflecting stronger underlying operations. Cash and cash equivalents were $600.6 million, and with an undrawn $1.0 billion revolver, total liquidity was about $1.6 billion. Long‑term debt, net, stood at $2,621.0 million, and the company remained in compliance with its debt covenants.

Rhea-AI Summary

Cushman & Wakefield (CWK) reported stronger Q3 results. Revenue rose to $2,605.9 million from $2,344.2 million, and operating income increased to $107.5 million from $75.2 million. Net income was $51.4 million, or $0.22 per diluted share, up from $0.14. Adjusted EBITDA reached $159.6 million versus $142.5 million. Year to date, revenue was $7,374.4 million and Adjusted EBITDA was $417.5 million.

The company continued to de‑risk its balance sheet. Long‑term debt, net, declined to $2,720.1 million from $2,939.6 million, reflecting $200.0 million of 2025 prepayments on term loans and spread reductions to 1‑month SOFR plus 2.75% on both 2030 tranches. Interest expense year to date decreased to $161.5 million from $174.4 million. Cash and cash equivalents were $634.4 million; the $1.1 billion revolver was undrawn. Segment revenue in Q3 was led by the Americas at $1,923.1 million, with EMEA at $260.1 million and APAC at $422.7 million. As of October 24, 2025, 231,604,548 ordinary shares were outstanding.